Powerful and proven software for preclinical drug discovery
MFI’s proprietary software platforms integrate suites of predictive tools that are a complement of biophysics and artificial intelligence, facilitating custom experimental design and enabling complete workflow automation without the need for third-party applications.
Drug Discovery Software
FITTED: Structure-based Drug Design
- Flagship Docking
- Covalent drug design
- Binding to metalloenzymes, other niche targets like RNA
IMPACTS: Metabolic Liabilities
- Cytochrome P450 prediction
- CYP oxidation, inhibition, induction
Computational Chemistry Software
REACT2D: Virtual Library Design and Chemoinformatics
- Chemical searching, analoging, clustering
- Rigorous combinatorial chemistry and chemistry fidelity (e.g., stereochemistry)
ACE: Catalyst Design
- Asymmetric catalysis
- Predict stereochemical outcomes
Learn More About MFI’s Software and What it Can Do
We will be posting updated technical spec sheets soon. In the meantime, to learn more about our technology and what it can do for you, please contact us directly.
Partnering with MFI can deliver a 30% reduction in the time and costs associated with preclinical drug discovery. Hit rates from our computational modeling can be a high as 15-20% versus the 1% of traditional high throughput screening.
–Josh Pottel, CEO